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IN THE LAST 20 YEARS, THERE HAVE BEENsignificant improvements in both the survival ofchildren with congenital heart disease, and in the
subsequent levels of functioning that such children
are expected to achieve.1 Correspondingly, there has
been an increasing awareness of the need also to con-
sider the health-related quality of life of these children.
Consistent with the United Nations Convention on
the Rights of the Child,2 there is a growing recogni-
tion that the views of children should be sought with
respect to decisions regarding their health. It follows,
therefore, that measures of health-related quality of life
should also reflect their views. It cannot be assumed
that others can supply this information, as studies have
shown considerable disagreement between the assess-
ment of their health by the children, and that of
respondents such as parents, physicians, and nurses.3,4
The current measures of health-related quality of
life in children with congenital cardiac disease have
recently been reviewed, and criticised because of poor
conceptual and methodological rigour.5 The review
stated that the term “quality of life” has been poorly
operationalised. For instance, a well-developed mea-
sure should have a scoring system that accounts for dif-
ferences in the relative importance to the respondent
of the various dimensions of quality of life it seeks to
measure.
The aim of our study, therefore, was to develop a
measure of health-related quality of life for use among
children with congenital cardiac disease. The intention
was that the new instrument would fulfil a number
of requirements:
 It would represent those aspects of health-related
quality of life considered important by children
with congenitally malformed hearts. The items in
the new measure are based on a series of qualita-
tive interviews with children and young people
with such congenitally malformed hearts. The
results of this part of the study have been reported
elsewhere.6
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 It would measure the impact of events or prob-
lems rather than just list their frequency.
 It would summarise data in a format that was
suitable for use in clinical trials by having a sin-
gle index score as one output.
 It would have both clinical and research applica-
tions so that it could be used by clinicians to
determine the needs of individual patients for care,
and to check that these needs had been met. To
ensure that the new measure would be acceptable
to all of the members of the multi-disciplinary
teams that work in the field of paediatric cardiol-
ogy and surgery, development work was guided
by a steering group that included representatives of
the children, specialist nurses, cardiologists, pae-
diatric cardiac surgeons, a paediatric cardiac mor-
phologist, physiotherapists, and psychologists.
We report here the development and assessment of
the ConQol.
Methods
Ethics
The protocol for the study received approval from
both the Multi-centric Research Ethics Committee
and local research governance committees. All par-
ticipants and their parents gave informed consent.
The development and validation was conducted in 
4 main phases.
Constructing the questionnaire. Two of the authors
generated potential items to represent the themes that
emerged from interviews, specifically physical symp-
toms, mood and cognition, restricted activities, rela-
tionships with others, control over health and the
body, and coping with illness. Wherever possible, 
the words or phrases used by the children were used in
the questions. The list of potential items was presented
to, and discussed by, the steering group. The items to
be included in the measure were agreed upon.
Piloting the questionnaire. The initial version of
the measure was piloted with a sample of children
with congenital cardiac malformations drawn from
the Yorkshire Heart Centre, who were asked to com-
plete the pilot version. This was to ascertain if there
were problems, for example, to ascertain if some items
were redundant or ambiguous. To encourage a good
return, all children who returned the scale received a
£5 gift voucher.
Deriving the weights for scoring. A sample of chil-
dren, parents, and health professionals were asked to
complete a postal “weighting” questionnaire which
required them to give each of the 22 quality of life
items included in the measure a score from zero to
10, where 10 equalled very important for quality of
life, and zero equalled no importance for quality of
life. Respondents were asked to score the worst theo-
retically possible manifestation of a state.
The weighting questionnaire consisted of 3 pages,
each presenting a vertical visual analogue scale with
10 points on the right hand side of the page, with
between 7 and 9 items listed on the left hand side.
Respondents were required to write a score for each
item in a box, rather than mark the visual analogue
scale. Two versions of the questionnaire were pro-
duced, which alternated the order in which items
were presented in the top and bottom halves of each
page. Respondents were instructed to imagine a child
aged between 8 and 16 years with a cardiac problem,
and to think about how important each item would
be for the quality of life of the individual child if he
or she had it for one week, and experienced that item
either “all the time”, or were not able to do it “as much
as they wanted to”, whichever was the worst response
for that item. Children with a cardiac problem were
also told that, if they wanted to, they could think
about themselves.
In addition, the sample of clinicians was also asked
to score the 13 symptom items in a similar fashion
on a visual analogue scale extending from zero to 10.
In this case, they were told to assume that each symp-
tom had been making the life of the child really dif-
ficult for a week.
Psychometric Performance. The validity and reliabil-
ity of the measure was assessed in a sample of chil-
dren with congenital cardiac malformations aged
between 8 and 16 years recruited from across the
United Kingdom.
Validity
The ConQol was validated in two ways, first by
observing its relationship with an established previ-
ously validated measure, the Paediatric Quality of
Life Inventory, and second, through its ability to dis-
criminate between children grouped in terms of the
severity of their disease.
The Paediatric Quality of Life Inventory7 is an
instrument for measuring health-related quality of life
in children and adolescents divided into three age-
specific versions. It has four core dimensions, namely
physical function, emotional function, social function,
and school function, plus a series of disease-specific,
bolt-on modules, including a cardiac module consist-
ing of six dimensions. These are cardiac problems 
and their treatment, treatment II, physical appearance,
anxiety about treatment, cognitive problems, and
communication.8 The dimensions of the inventory are
scored on a scale from zero to 100, where 100 indicates
least problems, and zero indicates most problems.
Two independent measures of severity of disease
or illness were included in the survey. First, children
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were classified according to the severity of their diag-
nosis using the guidelines set at the 32nd Bethesda
Conference of the American College of Cardiology.9
Clear classifications are given for categorising condi-
tions into three groups, namely simple, such as 
isolated congenital aortic valvar disease, moderate
complexity, such as moderate-to-severe pulmonary
valvar disease, and great complexity, such as double
outlet ventricle. Children were classified into the
appropriate category by a researcher with a nursing
background in paediatric cardiology.
Second, respondents were asked to report the extent
to which they felt their cardiac condition affected
their daily life on a three point scale, specifically that
it does not affect my daily life, it affects my daily life
a bit, or it affects my daily life a lot.
Reliability
The reliability of the measure was assessed by exam-
ining its internal consistency, and its reliability at
re-testing. The latter was assessed for a random sub-
sample of 100 children who had already returned ques-
tionnaires. They were asked to complete the measure
for a second time six weeks after the first. Of the
group, 79 children replied.
A sample of children aged from 8 to 16 were then
randomly selected from six centres for Paediatric
Cardiology across the United Kingdom, namely
Southampton General Hospital, Freeman Hospital,
Newcastle, Royal Liverpool Children’s National
Health Service Trust, Great Ormond Street Hospital
for Children National Health Service Trust, London,
Royal Hospital for Sick Children, Glasgow, and the
Yorkshire Heart Centre, Leeds General Infirmary.
They were selected from the databases of each centre
using a pre-generated random number table. Criteri-
ons for exclusion were having a level of cognitive
functioning that would impair the ability to com-
plete the questionnaire, or an inability to understand
English. Hospital staff checked the resulting lists to
ensure that families were not contacted inappropri-
ately. Packs were sent from the centres to the parents
of children and young people. Each pack contained a
letter of introduction from the consultant, an infor-
mation sheet for the child, a parental information
sheet, a questionnaire containing the ConQol and 
the Paediatric Quality of Life Inventory, and a pre-
paid reply envelope. A reminder was sent to non-
responders after 4 weeks. All children who returned
their questionnaire received a £5 gift voucher.
Results
Constructing the questionnaire
Item generation. A list of 50 potential items was
produced and examined by the steering committee. 
A number of items were discarded as repetitive, unsuit-
able, or ambiguous, and the items in the dimensions
of physical symptoms, and mood and cognition, were
grouped together to form a single dimension relating
to symptoms. Similarly, items in the dimensions con-
cerning control over health and body, and coping
with illness, were grouped together.
Interviews had revealed that the concerns of older
and younger children were different. Most notably,
older children were far more likely to talk about prob-
lems with coping and control. For this reason, we
developed two versions of the questionnaire, one for
those aged from 8 to 11 years, and one for the group
aged from 12 to 18 years. This split also reflected the
transition between primary school and secondary
school, as children appeared to have different experi-
ences in these two settings. The version for the
younger patients contained 31 items grouped into
dimensions of symptoms, ability to do activities, and
relationships with others. The version for the older
patients had an extra dimension relating to control
and coping, and contained 39 items.
Scaling responses. As the new measure aimed to
assess the extent to which children felt their cardiac
disease affected their life, a continuous response for-
mat was deemed most appropriate. Hence, a visual
analogue scale was chosen as the best method. In the
version for the younger patients, the anchor points
on the visual analogue scale were illustrated using
sad and happy faces to indicate the direction of the
scale. For items forming the dimension of symp-
toms, the frequency with which they were experi-
enced was also measured on a 4-point categorical
scale, with responses for every day, most days, a few
days, or not at all as well as the extent to which they
made life difficult on the visual analogue scale.
Following discussion with the expert steering com-
mittee, a recall period of one week was specified for the
measure. It was felt that younger children in particu-
lar would struggle to recall their behaviour or feelings
over a longer period, and that a shorter period would
allow the questionnaire to be repeated over a short
time interval, for example before and after surgery or
commencement of a new medical treatment.
Piloting the questionnaire
The measures were piloted in a randomly selected
group of children and young people under the care of
the Yorkshire Heart Centre. Families were approached
by post with a covering letter from the consultants.
A total of 320 children and young people were sent
a copy of the measure, of which 171, or 53%, returned
completed questionnaires.
The performance of the measure was scrutinised in
terms of its coverage, frequency of endorsement, and
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structure of dimensions. This process is described in
more detail in the User manual.10 Analysis revealed
that the questionnaire appeared to be acceptable to
both younger and older children, with low levels of
missing data. Of the items relating to symptoms,
one or two had relatively low frequencies of endorse-
ment, but were retained for completeness of coverage.
The intention was to have as many common items as
possible across the versions for the patients of different
ages. A few items, nonetheless, discriminated either
younger or older children, and so were only retained
for the appropriate version. After discussion with the
steering group, the decision was made to reduce the
upper age limit to 16 years, as many of the questions
asked about school-related issues were not appropriate
for those who had left school, as many young people
have by 16 years of age.
The final ConQol measures consisted of a 35-item
scale for those aged from 12 to 16 years, and covered
4 dimensions. These related to symptoms, comprising
13 items, activities, comprising 7 items, relationships,
comprising 10 items, and control and coping, com-
prising 5 items. The version for those aged from 8 to
11 years covered 3 dimensions, namely symptoms,
comprising 13 items, activities, comprising 6 items,
and relationships, comprising 10 items.
Deriving the weights for scoring
A random sub-sample of 120 of the children who
took part in the piloting, along with one of their par-
ents or carers, was invited to complete the weighting
exercise. Of this group, 82 children, and 78 parents,
responded giving response rates of 68% and 65%,
respectively. A control group of 45 children from two
local schools, matched for age range, and with no car-
diac disease, was also asked to complete the question-
naire. From this group, 38 (84%) questionnaires were
returned. In addition, weighting questionnaires were
also distributed to 70 health professionals recruited via
the six collaborating centres. Of these, 33 (47%) were
returned.
As the ConQol was developed with a child-centred
philosophy, it was decided that the weights used to
score it should be those elicited from children with
congenital cardiac disease. The weights generated by
the other groups may be used if researchers have spe-
cific interest, and are reproduced in the ConQol user
manual.10 Table 1 presents the mean weights for
each of the 22 quality of life items contained in the
ConQol. Of the children providing data, 65% indi-
cated that they thought about themselves when they
were completing the exercise.
Table 2 presents the mean weights for the 13 items
for symptoms as scored by the sample of health 
professionals.
Children ranked breathlessness and tiredness as
the most significant symptoms, with items related
to cognitive function being the least significant 
to them.
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Table 1. Quality of life item scoring weights.
Children with
congenital heart
disease
Quality of life item Mean (rank) SD
Activities
Able to run about 7.23 (14) 2.7
Allowed to do sports and exercise 6.96 (20) 2.6
Able to spend time with friends 8.29 (2) 2.2
Able to keep up with friends 7.80 (8) 1.9
Able to go to clubs/do activities 6.87 (21) 2.7
outside of school
Able to go to town shopping 7.13 (16) 2.5
with friends
Allowed to do things friends do 7.55 (10) 2.4
Relationships
Get on well with friends 8.15 (4) 2.0
Friends look out for me 7.72 (9) 2.0
Find it hard to make friends 7.99 (5) 2.0
People fuss over me too much 6.12 (24) 2.3
Get picked on and teased 8.32 (1) 2.3
Feel lonely 8.18 (3) 2.4
Allowed to do things able to do 7.98 (6) 1.8
People expect me to do too much 6.98 (19) 2.2
Can do more than people think 7.21 (15) 2.1
People understand what I can 6.99 (17) 2.1
manage to do
Control of health/body
Feel like my body is not my own 6.99 (17) 2.9
Feel like my health is out of my hands 7.41 (11) 2.6
Fed up with telling people 6.54 (23) 2.6
about health
I think about my heart 6.62 (22) 2.6
Life is good 7.87 (7) 2.6
Shaded items are items which only appear in the questionnaire for
older children
Table 2. Symptom item scoring weights from health
professionals.
Item Mean (rank) SD
Short of breath or puffed out 9.15 (1) 1.1
Too tired 8.67 (2) 1.2
Aches and pains 8.24 (9) 1.3
Dizzy or faint 8.58 (4) 1.4
Unable to keep up with schoolwork 8.12 (10) 1.6
or homework
Difficulty concentrating 8.09 (11) 1.5
Forgetful 7.73 (13) 1.7
Slowed down thoughts 7.79 (12) 1.7
Sad or fed up 8.42 (5) 1.6
Worried or nervous 8.42 (5) 1.6
Feeling different to others 8.59 (3) 1.8
Feel like treated differently to others 8.27 (8) 1.9
Uncomfortable with looks 8.28 (7) 1.8
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Scoring. The ConQol is scored by multiplying
the score for each item by the mean weight for that
item, and summing the resulting scores. Scores are
calculated as a proportion of the maximum score
possible, and multiplied by 100 to provide a posi-
tion on a scale from zero to 100, where zero equals
worst quality of life, and 100 equals best quality of
life. This standardisation allows for scores from the
two different versions of the ConQol to be compared.
Separate scores are generated for the items relating
to quality of life items, the index score, and those
relating to symptoms, the ConQol symptom score.
Psychometric performance
The ConQol was sent to 1416 children with congen-
ital cardiac disease, of which 640 (44%) returned a
completed questionnaire. The number of children
contacted in each centre, and the rates of response,
are shown in Table 3. Of those responding, 171 were
classified as having a disease of great complexity,
223 were classified as having a disease of moderate
complexity and 227 were classified as having simple
conditions. In those aged from 8 to 11 years, the mean
age was 10 years, with standard deviation of 1.18, and
comprised 52% male and 48% female respondents.
In the group containing those aged from 12 to 16,
the mean age was 14 years, with standard deviation
of 1.32, and the group was comprised of 51% males
and 48% females.
The mean index score for the younger patients was
75.04, with standard deviation of 17.65, and for the
older patients was 76.02, with standard deviation of
14.91. Figures 1 and 2 present the distribution of the
index score for both groups.
Relationship with Paediatric Quality of 
Life Inventory
Table 4 shows the relationship between the dimen-
sions as represented in the Paediatric Quality of Life
Inventory and the ConQol index score.
Overall correlations tended to be higher for older
compared to younger children. The relationship for
the dimension of treatment II in the Inventory was
particularly low for younger children.
For both groups, the ConQol index score correlated
best with the core dimensions of the Inventory, along
with the dimension of heart problems and treatment
from the cardiac module. For younger children, the
best correlation was achieved with the dimension relat-
ing to social function (r equal to 0.67), followed by that
for heart problems (r equal to 0.58). For older children,
social function again showed the best relationship
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Table 3. Response rates by study centre.
Centre Sample Response (%)
Newcastle 250 108 (43%)
Southampton 250 126 (50%)
London 232 95 (41%)
Leeds 241 129 (53%)
Liverpool 200 100 (50%)
Glasgow 243 114 (47%)
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Figure 1.
Frequency distribution of ConQol index scores in 8–11 year olds.
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Figure 2.
Frequency distribution of ConQol index scores in 12–16 year olds.
Table 4. Correlations (Pearson’s r) between ConQol index score
and Paediatric Quality of Life Inventory dimensions scores.
ConQol index ConQol index
8–11 years 12–16 years
Physical function 0.53 0.67
Emotional function 0.51 0.60
Social function 0.67 0.70
School function 0.52 0.59
Heart problems  treatment 0.58 0.62
Treatment II 0.07 0.49
Physical appearance 0.39 0.44
Treatment anxiety 0.48 0.41
Cognitive problems 0.52 0.56
Communication 0.42 0.56
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with ConQol index score (r equal to 0.70), followed
by physical function (r equal to 0.67).
Relationship with severity of disease
Table 5 presents the mean ConQol index scores by
severity according to the classification of the American
College of Cardiology for both groups.
Analysis of variance showed that, among the
younger patients, those children with cardiac prob-
lems classified as being of great complexity had sig-
nificantly lower ConQol index scores than children
with less severe problems. Children who were classi-
fied to the simple category had a lower mean ConQol
index score than children who were classified as hav-
ing a condition of moderate complexity. This differ-
ence, however, was not statistically significant. In
terms of self-report of how much their cardiac condi-
tion affected their daily life, there was a significant
decrease in ConQol index scores as children in this
younger age group increasingly reported an influ-
ence of their illness on their day-to-day life.
Among children aged from 12 to 16 years, there
were no significant differences in ConQol index score
by severity of disease. The ConQol index score, nonethe-
less, was able to discriminate between children in this
age group according to how much they reported their
cardiac condition affected their daily life.
Reliability
For both age groups, Cronbach’s a for the ConQol
index score was 0.86, which reflects a good level of
internal consistency. Intra-class correlation coefficients
were calculated to assess reliability for re-testing. For
both age groups, the intra-class correlation coeffi-
cients for the ConQol index score were 0.7 or above.
Paired t-tests also indicated that the mean scores for
both age groups at were not significantly different at
testing and re-testing.
Discussion
The final ConQol measure comprises two versions, a
scale with 29 items for children aged from 8 to 12
years, and one with 35 items for children aged from
12 to 16 years. It provides clinicians and researchers
with 3 outputs that summarise how a child has been
feeling in the past week:
 a single index of quality of life that measures the
extent to which respondents feel limited in terms
of their activities and relationships with others.
 a single index for symptoms that measures the
extent to which respondents feel the symptoms of
their disease have made their life difficult.
 a descriptive profile recording the number and
frequency of symptoms experienced by the child
in the past week.
The indexes are standardised for scores on a scale
extending from zero to 100, permitting scores for the
different versions for age to be compared. For the
purposes of research or audit, the quality of life score
provides a single measure that can be used to record
change in quality of life, but also identifies the expe-
rience of the individual child in those areas of life
rated as most important to their quality of life. We
hope that the measure will be routinely used by
healthcare staff providing rehabilitation and support
to children as part of their normal clinical practice to
identify areas of life where a particular child is strug-
gling or has an unusual level of difficulty. It can be
used to initiate a discussion of these areas when a ver-
bal question will often generate the response of “it’s
OK” from a child. The measure can be repeated to
provide evidence that the help provided has resolved
the problem.
In a similar way, it provides a valid and reliable
profile of the load of symptoms, descriptively in terms
of which symptoms and how often, and in terms of
the perspective of the child. We believe that it may
be a useful addition to structuring consultations, and
guiding and balancing therapeutic interventions,
allowing them to be based on alleviating those symp-
toms considered most difficult by the child, or those
found most disruptive, rather than using the assump-
tions of parents and clinicians, which we know are
sometimes misleading. The index score for symptoms
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Table 5. Mean ConQol index score by disease severity, 
according to the American College of Cardiology classification.
Mean (SD) 95% CI N
8–11 year olds
Great complexity 69.4 (19.2) 65.5–73.3 96
Moderate complexity 78.2 (15.5) 75.0–81.3 94
Simple 76.8 (17.2) 73.8–79.9 124
p  0.01
Heart condition affects daily life
Not at all 78.9 (16.6) 76.4–81.3 183
A bit 71.1 (16.3) 68.0–74.2 107
A lot 57.8 (21.5) 47.7–67.8 20
p  0.001
12–16 year olds
Great complexity 75.0 (17.2) 71.0–79.0 75
Moderate complexity 74.6 (14.2) 72.1–77.0 131
Simple 78.5 (14.5) 75.8–81.2 112
ns
Heart condition affects daily life
Not at all 81.6 (11.7) 80.0–83.2 199
A bit 69.5 (13.2) 66.9–72.0 106
A lot 53.4 (16.1) 45.7–61.4 18
p  0.001
1602-11.qxd  3/15/06  11:48 AM  Page 170
may also be used to assess any changes in the impact
of symptoms experienced from any change in ther-
apy or a surgical intervention.
In these ways, we hope that it can provide a useful
tool for informing clinical decision-making. For exam-
ple, the timing of corrective and palliative surgical
procedures is currently based on maximising cardiac
functioning. In the absence of a valid measure of
health-related quality of life, it is impossible to estab-
lish the extent of the trade-off, if any, between med-
ical and health-related outcomes.
It must be remembered, however, that although
the children did report the symptom included 
in the ConQol, they were not on the whole viewed
by them as being problematic. The clinicians on the
steering committee felt strongly that, despite this,
the report of symptoms provides useful information
about the pattern and nature of symptoms, which
may not always be discussed if they are not raised by
children or their parents. They accepted that, for the
reasons given above, this must be scored and reported
separately from the items relating to quality of life,
and that it should not be used as a proxy for quality 
of life.
In addition to the clinical, research and audit pur-
poses, the ConQol could provide epidemiological data
systematically to examine the relationships between
physical, psychological, and social variables to deter-
mine the most common risk factors for poor health-
related quality of life.
Data from a large sample of children with con-
genital cardiac disease drawn from across the United
Kingdom have provided evidence that the ConQol
exhibits good reliability and validity. Correlations
with the Paediatric Quality of Life Inventory were
sufficient to demonstrate validity, but not so high as
to make the ConQol redundant. The ConQol index
score did not cover many of the cardiac-specific items
included in that measure, such as experience of treat-
ment, or problems with medication, because children
did not indicate that these areas were significant in
terms of their quality of life.
That the correlations with the Paediatric Quality
of Life Inventory were only moderate was what we had
expected, because the ConQol was developed using a
child-centred philosophy in line with current best
practice. The items of the ConQol that contribute to
its score concerning quality of life were derived from
those topics that children with congenital cardiac dis-
ease considered important in determining their qual-
ity of life, and did not rely on the views of “experts”,
psychologists, clinicians, or parents. The same child-
centred approach also underlies the scoring system
used to generate the ConQol score for quality of life.
The weights used to generate this score were based
on the estimations of children with cardiac disease of
how significant each item would be in influencing
quality of life. For those who wish also to know the
effect of scoring it from the perspective of parents or
clinicians, the relevant weightings are provided in the
accompanying manual.
There was a trend towards young people with
more complex conditions reporting poorer quality of
life, and those young people who reported their con-
dition as having a great deal of impact on their daily
life did differ statistically in this respect from those
who did not feel their condition impacted on their
daily life. The fact that complexity was not a stronger
differentiator of quality of life was not surprising to
us, as it is a common finding in research related to
quality of life that the “seriousness” of the underly-
ing lesion is often only weakly related to perceived
quality of life. An additional difficulty in this area is
that we were unable to find a universally agreed sys-
tem for determining the severity of disease. Future
research might usefully investigate the discriminant
validity of the ConQol using other methods. In 
addition, future work is required to establish its
responsiveness or sensitivity to change. The measure
appeared to be acceptable to respondents, possibly
because, at the piloting stage, a number of modifica-
tions were made using feedback from children.
Although it is relatively long, at 29 or 35 items there
were very few missing item responses. The measure is
designed to be self completed, and was administered
as a postal questionnaire with very few problems. A
useful strategy can be to ask the child to complete
the questionnaire whilst in the waiting room, or
prior to attending. With a little experience, it can be
quickly scanned before the consultation or interview
to see where there may be problems. Future research
might be conducted to determine if a “short form”
could be constructed without loosing psychometric
quality.
Future Work
While the ConQol addresses the issues of quality of
life of importance to children between 8 and 16 years
of age, it was not designed to collect data from
younger children or older young people. The research
team were committed to a child-centred approach,
and the design of the study allowed us to address the
issues important to the age group identified. Further
studies will be required in order to identify the impor-
tant areas for younger children, which may be quite
different. Indeed, questionnaires may not be the most
appropriate method for elucidating their feelings. 
A new measure for young adults with congenital
heart disease has been developed and validated along
similar lines to the ConQol, and could be used for
that age group.11
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Limitations
Although the method of selecting children and young
people to participate in this study was designed to
reduce bias in selection as far as possible, the overall
rate of response was 44%. While this is a common
problem with postal studies, and our response rate
does not differ significantly from other large postal
studies, such as those conducted in the United
Kingdom by the Department of Health, there may
be an associated risk of non-response bias. The lim-
ited information available on the children who did
not respond did not indicate any differences in terms
of the spread of severity of disease, or age. The sam-
ples were drawn from hospital databases of variable
quality and accuracy, so it may be the case that some
of those who did not respond may have had little or
no clinical contact for a number of years, or been dis-
charged, or moved, or have had few if any problems
to report, and thus did not feel that their responses
would be appropriate. Anecdotally, we know that
some felt that their problem was cured, and that they
no longer had congenital cardiac disease, because when
parents contacted the research centre by telephone,
they often asked if this assumption was justified.
Conclusions
Our study reports the initial development of a new
measure for outcomes in children and young people
with congenital cardiac disease, aged between 8 and
16 years. Developed using a child-centred perspec-
tive, it is valid and reliable, and shows discrimina-
tion according to the severity of disease. It can be used
in a clinical setting, and its acceptability to both
children and their parents was established during its
development.
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